Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors “A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome”

Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research